Cellumen, NCTR Collaborate on Liver Toxicity Testing | GenomeWeb
NEW YORK (GenomeWeb News) – Cellumen said today that it has entered into a research collaboration with the National Center for Toxicological Research, part of the US Food and Drug Administration, to test known liver toxicity drugs.
Cellumen will use its CellCiphr cell-based assay to create profiles of blinded samples of these compounds from failed and marketed drugs, and the NCTR will incorporate information about these drugs into a liver toxicity knowledge database.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.